Characterization of a Murine Monoclonal Antibody to Cryptococcus neoformans Polysaccharide That Is a Candidate for Human Therapeutic Studies

Cited by (297)

Items 101–200 of 297

1. Cryptococcus neoformansInduces Macrophage Inflammatory Protein 1α (MIP-1α) and MIP-1β in Human Microglia: Role of Specific Antibody and Soluble Capsular Polysaccharide
   David A Goldman, Xianyuan Song, Ryuhei Kitai, Arturo Casadevall, Meng‐Liang Zhao, Sunhee C. Lee · 2001 · Infection and Immunity
2. Intranasal Inoculation of Cryptococcus neoformans in Mice Produces Nasal Infection with Rapid Brain Dissemination
   Carolina Coelho, Emma Camacho, Antonio Salas, Alexandre Alanio, Arturo Casadevall · 2019 · mSphere
3. Methamphetamine Enhances Cryptococcus neoformans Pulmonary Infection and Dissemination to the Brain
   Patel, Dhavan, Desai, Gunjan M., Frases, Susana, Cordero, Radames J. B., DeLeon-Rodriguez, Carlos M., Eugenin, Eliseo A., Nosanchuk, Joshua D., Martinez, Luis R. · 2013 · mBio
4. Combined treatment: antifungal drugs with antibodies, cytokines or drugs
   David A. Stevens, Bart Jan Kullberg, Elmer Brummer, Arturo Casadevall, Mihai Gheorghe Netea, Alan M. Sugar · 2000 · Medical Mycology
5. Neutrophils from Patients with Advanced Human Immunodeficiency Virus Infection Have Impaired Complement Receptor Function and Preserved Fcγ Receptor Function
   Claudia Monari, Arturo Casadevall, Donatella Pietrella, Francesco Bistoni, Anna Vecchiarelli · 1999 · The Journal of Infectious Diseases
6. Diagnosis and management of cryptococcal meningitis in HIV-infected adults
   Thomas C McHale, David R. Boulware, John Kasibante, Kenneth Ssebambulidde, Caleb P Skipper, Mahsa Abassi · 2023 · Clinical Microbiology Reviews
7. The Elastic Properties of the Cryptococcus neoformans Capsule
   Susana Frasés, Bruno Pontes, Leonardo Nimrichter, Márcio Lourenço Rodrigues, Nathan Bessa Viana, Arturo Casadevall · 2009 · Biophysical Journal
8. Intracellular Crystal Formation as a Mechanism of Cytotoxicity in Murine PulmonaryCryptococcus neoformansInfection
   Marta Feldmesser, Yvonne Kress, Arturo Casadevall · 2001 · Infection and Immunity
9. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy
   Thiago Aparecido da Silva, Paul J. Hauser, Irfan N. Bandey, Tamara J. Laskowski, Qi Wang, Amer M. Najjar, Pappanaicken R. Kumaresan · 2020 · Cytotherapy
10. Characterization of Scedosporium apiospermum Glucosylceramides and Their Involvement in Fungal Development and Macrophage Functions
    Rodrigo Rollin‐Pinheiro, Livia Cristina Liporagi-Lopes, Jardel Vieira de Meirelles, Lauro Mera de Souza, Eliana Barreto‐Bergter · 2014 · PLoS ONE
11. Variation in Cell Surface Hydrophobicity among Cryptococcus neoformans Strains Influences Interactions with Amoebas
    Raghav Vij, Carina Danchik, Conor J. Crawford, Quigly Dragotakes, Arturo Casadevall · 2020 · mSphere
12. Chronological Aging Is Associated with Biophysical and Chemical Changes in the Capsule of Cryptococcus neoformans
    Radamés J. B. Cordero, Bruno Pontes, Allan Jefferson Guimaraes, Luis R. Martinez, Johanna Rivera, Bettina C. Fries, Leonardo Nimrichter, Márcio Lourenço Rodrigues, Nathan Bessa Viana, Arturo Casadevall · 2011 · Infection and Immunity
13. A Monoclonal Antibody toHistoplasma capsulatumAlters the Intracellular Fate of the Fungus in Murine Macrophages
    Shi Li, Priscila Costa Albuquerque, Eszter Lázár‐Molnár, Xintao Wang, Laura Santambrogio, Attila Gácser, Joshua Daniel Nosanchuk · 2008 · Eukaryotic Cell
14. Antibody Binding to Cryptococcus neoformans Impairs Budding by Altering Capsular Mechanical Properties
    Radamés J. B. Cordero, Bruno Pontes, Susana Frasés, Antonio S. Nakouzi, Leonardo Nimrichter, Márcio Lourenço Rodrigues, Nathan Bessa Viana, Arturo Casadevall · 2012 · The Journal of Immunology
15. Nutritional Conditions Modulate C. neoformans Extracellular Vesicles’ Capacity to Elicit Host Immune Response
    Clara Luna Marina, Pedro Henrique Bürgel, Daniel Paiva Agostinho, Daniel Zamith‐Miranda, Lucas de Oliveira Las-Casas, Aldo Henrique Tavares, Joshua Daniel Nosanchuk, Anamélia Lorenzetti Bocca · 2020 · Microorganisms
16. Current trends to control fungal pathogens: exploiting our knowledge in the host–pathogen interaction
    Laura Cristina García-Carnero, Luis A. Pérez-García, José A. Martínez-Álvarez, Juana Elizabeth Reyes-Martínez, Hector Manuel Mora-Montes · 2018 · Infection and Drug Resistance
17. Inositol Metabolism Regulates Capsule Structure and Virulence in the Human Pathogen Cryptococcus neoformans
    Yina Wang, Maggie P. Wear, Gurkirat Kohli, Raghav Vij, Charles Giamberardino, Arpun Shah, Dena L. Toffaletti, Chen-Hsin A. Yu, John R. Perfect, Arturo Casadevall et al. · 2021 · mBio
18. Analysis of multiple components involved in the interaction between Cryptococcus neoformans and Acanthamoeba castellanii
    Juliana Rizzo, Priscila Costa Albuquerque, Julie M. Wolf, Renata Nascimento, Marcos Dias Pereira, Joshua Daniel Nosanchuk, Márcio Lourenço Rodrigues · 2017 · Fungal Biology
19. Biosynthesis and Immunogenicity of Glucosylceramide inCryptococcus neoformansand Other Human Pathogens
    Ryan M. Rhome, Travis J. McQuiston, Talar B. Kechichian, Alicja E. Bielawska, Mirko Hennig, Monica Drago, Giulia Morace, Chiara Luberto, Maurizio Del Poeta · 2007 · Eukaryotic Cell
20. FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages
    Arielle M. Bryan, Jeehyun Karen You, Travis J. McQuiston, C. Lazzarini, Zhijuan Qiu, Brian S. Sheridan, Barbara Nuesslein‐Hildesheim, Maurizio Del Poeta · 2020 · Journal of Clinical Investigation
21. Phagocytic Activity and Monocyte Chemotactic Protein Expression by Pulmonary Macrophages in Persistent Pulmonary Cryptococcosis
    Wu He, Arturo Casadevall, Sunhee C. Lee, David L. Goldman · 2003 · Infection and Immunity
22. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance
    Óscar Zaragoza, Arturo Casadevall · 2006 · Cellular Microbiology
23. Modulation of Macrophage Inflammatory Nuclear Factor κB (NF-κB) Signaling by Intracellular Cryptococcus neoformans
    James B. Hayes, Linda M. Sircy, Lauren E. Heusinkveld, Wandi Ding, Rachel N. Leander, Erin E. McClelland, David E. Nelson · 2016 · Journal of Biological Chemistry
24. Association Between Plasma Antibody Responses and Risk for Cryptococcus-Associated Immune Reconstitution Inflammatory Syndrome
    Hyunah Yoon, Antonio S. Nakouzi, Christina C. Chang, Mark H. Kuniholm, Leandro J. Carreño, Tao Wang, Thumbi Ndung’u, Sharon R. Lewin, Martyn A. French, Liise‐anne Pirofski · 2018 · The Journal of Infectious Diseases
25. Immunomodulatory activity of β-glucan-containing exopolysaccharides from Auricularia auricular in phagocytes and mice infected with Cryptococcus neoformans
    Angelina Maria Moreschi Basso, Raffael Júnio Araújo de Castro, Tialfi Bergamin de Castro, Helena Ipe Pinheiro Guimaraes, Vera Lúcia Perussi Polez, Elaine Rosechrer Carbonero, Vitor Hugo Pomin, Christian Hoffmann, Maria Fátima Grossi‐de‐Sá, Aldo Henrique Tavares et al. · 2019 · Medical Mycology
26. Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans
    Claudia Monari, Arturo Casadevall, Cinzia Retini, Franco Baldelli, Francesco Bistoni, Anna Vecchiarelli · 1999 · AIDS
27. Vaccine and Immunotherapeutic Approaches for the Prevention of Cryptococcosis: Lessons Learned from Animal Models
    Camaron R. Hole, Floyd L. Wormley · 2012 · Frontiers in Microbiology
28. Anti-glycan monoclonal antibodies: Basic research and clinical applications
    Kara M. Gillmann, J. Sebastian Temme, Samantha Marglous, Claire E. Brown, Jeffrey C. Gildersleeve · 2023 · Current Opinion in Chemical Biology
29. Effect of Virulence Factors on the Photodynamic Inactivation of Cryptococcus neoformans
    Renato Araújo Prates, Beth Burgwyn Fuchs, Kazue Mizuno, Qurat Naqvi, Ilka Tiemy Kato, Martha Simões Ribeiro, Eleftherios E Mylonakis, George P. Tegos, Michael Richard Hamblin · 2013 · PLoS ONE
30. Vaccines and Protective Immune Memory against Cryptococcosis
    Keigo Ueno, Nao Yanagihara, Kiminori Shimizu, Yoshitsugu Miyazaki · 2020 · Biological and Pharmaceutical Bulletin
31. A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response
    Rebekah A. Robinette, Monika W. Oli, William P. McArthur, L. Jeannine Brady · 2011 · Vaccine
32. Cryptococcus neoformans -Reactive and Total Immunoglobulin Profiles of Human Immunodeficiency Virus-Infected and Uninfected Ugandans
    Krishanthi S. Subramaniam, Neil French, Liise‐anne Pirofski · 2005 · Clinical and Vaccine Immunology
33. Cryptococcus neoformans and Cryptococcosis
    Thomas Stephen Harrison · 2000 · Journal of Infection
34. Binding of Glucuronoxylomannan to the CD14 Receptor in Human A549 Alveolar Cells Induces Interleukin-8 Production
    Barbosa, Fabiane M., Fonseca, Fernanda L., Figueiredo, Rodrigo T., Bozza, Marcelo T., Casadevall, Arturo, Nimrichter, Leonardo, Rodrigues, Marcio L. · 2007 · Clinical and Vaccine Immunology
35. Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis
    Fernanda L. Fonseca, Allan Jefferson Guimaraes, Lívia Kmetzsch, Fabianno F. Dutra, Fernanda Dias da Silva, Carlos P. Taborda, Glauber Ribeiro de Sousa Araújo, Susana Frasés, Charley Christian Staats, Marcelo Torres Bozza et al. · 2013 · Fungal Genetics and Biology
36. The calcium transporter P mc1 provides C a2+ tolerance and influences the progression of murine cryptococcal infection
    Lívia Kmetzsch, Charley Christian Staats, Julia B. Cupertino, Fernanda L. Fonseca, Márcio Lourenço Rodrigues, Augusto Schrank, Marilene Henning Vainstein · 2013 · FEBS Journal
37. Antibody-Guided Alpha Radiation Effectively Damages Fungal Biofilms
    Luis R. Martinez, Ruth A. Bryan, Christos Apostolidis, Alfred Morgenstern, Arturo Casadevall, Ekaterina Dadachova · 2006 · Antimicrobial Agents and Chemotherapy
38. Harnessing the Immune Response to Fungal Pathogens for Vaccine Development
    Amariliz Rivera, Jennifer K. Lodge, Chaoyang Xue · 2022 · Annual Review of Microbiology
39. Dependence of Macrophage Phagocytic Efficacy on Antibody Concentration
    Nataša Macura, Tong Zhang, Arturo Casadevall · 2007 · Infection and Immunity
40. The role of macrophages in the susceptibility of Fc gamma receptor IIb deficient mice to Cryptococcus neoformans
    Saowapha Surawut, Thunnicha Ondee, Sujittra Taratummarat, Tanapat Palaga, Prapaporn Pisitkun, Ariya Chindamporn, Asada Leelahavanichkul · 2017 · Scientific Reports
41. Galactoxylomannan-Mediated Immunological Paralysis Results from Specific B Cell Depletion in the Context of Widespread Immune System Damage
    Magdia De Jesus, André Moraes Nicola, Susana Frasés, Ian R Lee, Steven Mieses, Arturo Casadevall · 2009 · The Journal of Immunology
42. Molecular Basis for Immunoglobulin M Specificity to Epitopes inCryptococcus neoformansPolysaccharide That Elicit Protective and Nonprotective Antibodies
    Antonio S. Nakouzi, Philippe Valadon, Joshua Daniel Nosanchuk, Nancy Green, Arturo Casadevall · 2001 · Infection and Immunity
43. Enhanced virulence of Histoplasma capsulatum through transfer and surface incorporation of glycans from Cryptococcus neoformans during co-infection
    Radamés J. B. Cordero, Susie Coutinho Liedke, Glauber Ribeiro de Sousa Araújo, Luis R. Martinez, Leonardo Nimrichter, Susana Frasés, José Mauro Peralta, Arturo Casadevall, Márcio Lourenço Rodrigues, Joshua Daniel Nosanchuk et al. · 2016 · Scientific Reports
44. Cryptococcus–Epithelial Interactions
    Leanne M. Taylor-Smith · 2017 · Journal of Fungi
45. Chitin-Like Molecules Associate with Cryptococcus neoformans Glucuronoxylomannan To Form a Glycan Complex with Previously Unknown Properties
    Caroline L. Ramos, Fernanda L. Fonseca, Jessica Rodrigues, Allan Jefferson Guimaraes, Leonardo Paes Cinelli, Kildare Rocha de Miranda, Leonardo Nimrichter, Arturo Casadevall, Luiz Rodolpho Travassos, Márcio Lourenço Rodrigues · 2012 · Eukaryotic Cell
46. The putative flippase Apt1 is required for intracellular membrane architecture and biosynthesis of polysaccharide and lipids in Cryptococcus neoformans
    Juliana Rizzo, Ana Caroline Colombo, Daniel Zamith‐Miranda, Vanessa K. A. Silva, Jeremy C. Allegood, Arturo Casadevall, Maurizio Del Poeta, Joshua Daniel Nosanchuk, James W. Kronstad, Márcio Lourenço Rodrigues · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
47. In Vitro and In Vivo Stability aCryptococcus neoformansGlucuronoxylomannan Epitope That Elicits Protective Antibodies
    Wendy Cleare, Robert Cherniak, Arturo Casadevall · 1999 · Infection and Immunity
48. Cholesterol and sphingomyelin are critical for Fcγ receptor–mediated phagocytosis of Cryptococcus neoformans by macrophages
    Arielle M. Bryan, Jeehyun Karen You, Guangtao Li, Jihyun Kim, Ashutosh Singh, Johannes Morstein, Dirk H. Trauner, Nívea Pereira de Sá, Tyler G. Normile, Amir Mohammad Farnoud et al. · 2021 · Journal of Biological Chemistry
49. Immunotherapy for invasive fungal infections: from bench to bedside
    Peter G. Pappas · 2004 · Drug Resistance Updates
50. Molecular and Idiotypic Analyses of the Antibody Response toCryptococcus neoformansGlucuronoxylomannan-Protein Conjugate Vaccine in Autoimmune and Nonautoimmune Mice
    Gabriel Nussbaum, Sharmila Anandasabapathy, Jean Mukherjee, Manxia Fan, Arturo Casadevall, Matthew D. Scharff · 1999 · Infection and Immunity
51. A glycan FRET assay for detection and characterization of catalytic antibodies to the Cryptococcus neoformans capsule
    Conor J. Crawford, Maggie P. Wear, Daniel F. Q. Smith, Clotilde d’Errico, Scott A. McConnell, Arturo Casadevall, Stefan Oscarson · 2021 · Proceedings of the National Academy of Sciences
52. Titan Cells and Yeast Forms of Cryptococcus neoformans and Cryptococcus gattii Are Recognized by GXMR-CAR
    Matheus Henrique dos Santos, Michele Procópio Machado, Pappanaicken R. Kumaresan, Thiago Aparecido da Silva · 2021 · Microorganisms
53. Unexpected Diversity in the Fine Specificity of Monoclonal Antibodies That Use the Same V Region Gene to Glucuronoxylomannan of Cryptococcus neoformans
    Diane C. McFadden, Arturo Casadevall · 2004 · The Journal of Immunology
54. A New Azole Derivative of 1,4-Benzothiazine Increases the Antifungal Mechanisms of Natural Effector Cells
    Lucia Pitzurra, Renata Fringuelli, Stefano Perito, Fausto Schiaffella, Roberta Barluzzi, Francesco Bistoni, Anna Vecchiarelli · 1999 · Antimicrobial Agents and Chemotherapy
55. Cryptococcus neoformans Secretes Small Molecules That Inhibit IL-1β Inflammasome-Dependent Secretion
    Pedro Henrique Bürgel, Clara Luna Marina, Pedro H. V. Saavedra, Patrícia Albuquerque, Stephan Alberto Machado de Oliveira, Paulo Henrique de Holanda Veloso Júnior, Raffael Júnio Araújo de Castro, Heino Martin Heyman, Carolina Coelho, Radamés J. B. Cordero et al. · 2020 · Mediators of Inflammation
56. Cryptococcus Neoformans Glucuronoxylomannan Fractions of Different Molecular Masses are Functionally Distinct
    Priscila Costa Albuquerque, Fernanda L. Fonseca, Fabianno F Dutra, Marcelo Torres Bozza, Susana Frasés, Arturo Casadevall, Márcio Lourenço Rodrigues · 2014 · Future Microbiology
57. A Dual Role For TGF-β1 in the Control and Persistence of Fungal Pneumonia
    Xiuping Shao, Johanna Rivera, Ramata Niang, Arturo Casadevall, David L. Goldman · 2005 · The Journal of Immunology
58. Lack of chitin synthase genes impacts capsular architecture and cellular physiology in Cryptococcus neoformans
    Jessica Rodrigues, Caroline L. Ramos, Susana Frasés, Rodrigo M. da C. Godinho, Fernanda L. Fonseca, Márcio Lourenço Rodrigues · 2018 · The Cell Surface
59. Monoclonal Antibody–Mediated Toxicity in Cryptococcus neoformans Infection: Mechanism and Relationship to Antibody Isotype
    Nikoletta K. Lendvai, Arturo Casadevall · 1999 · The Journal of Infectious Diseases
60. Cell Wall-Associated Virulence Factors Contribute to Increased Resilience of Old Cryptococcus neoformans Cells
    Erika P. Orner, Somanon Bhattacharya, Klea Kalenja, Danielle Hayden, Maurizio Del Poeta, Bettina C. Fries · 2019 · Frontiers in Microbiology
61. Proteome and secretome profiling of zinc availability in Cryptococcus neoformans identifies Wos2 as a subtle influencer of fungal virulence determinants
    Brianna Ball, Elizabeth Woroszchuk, Arjun Sukumaran, H. West, A. Afaq, Duncan Carruthers‐Lay, Benjamin Muselius, L. Gee, M. Langille, Samanta Pladwig et al. · 2021 · BMC Microbiology
62. Modulation of Replicative Lifespan in Cryptococcus neoformans: Implications for Virulence
    Tejas Bouklas, Neena Jain, Bettina C. Fries · 2017 · Frontiers in Microbiology
63. Relative Contributions of Prenylation and Postprenylation Processing in Cryptococcus neoformans Pathogenesis
    Shannon K. Esher, Kyla S. Ost, Lukasz Kozubowski, Dong‐Hoon Yang, Min Su Kim, Yong‐Sun Bahn, J. Andrew Alspaugh, Connie B. Nichols · 2016 · mSphere
64. Intracellular Cryptococcus neoformans disrupts the transcriptome profile of M1- and M2-polarized host macrophages
    Aarthi Subramani, Prianca Griggs, Niah Frantzen, James Mendez, Jamila S. Tucker, Jada Murriel, Linda M. Sircy, Grace E. Millican, Erin E. McClelland, Rebecca L. Seipelt-Thiemann et al. · 2020 · PLoS ONE
65. Pathogenic diversity amongst serotype C VGIII and VGIV Cryptococcus gattii isolates
    Jéssica Rodrigues, Fernanda L. Fonseca, Rafael Schneider, Rodrigo M. da C. Godinho, Carolina Firacative, Krystyna Maszewska, Wieland Meyer, Augusto Schrank, Charley Christian Staats, Lívia Kmetzsch et al. · 2015 · Scientific Reports
66. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain
    Floyd L. Wormley, Gary M. Cox, John R. Perfect · 2005 · Microbial Pathogenesis
67. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan
    Priscila Costa Albuquerque, Radamés J. B. Cordero, Fernanda L. Fonseca, Roberta Peres da Silva, Caroline L. Ramos, Kildare Rocha de Miranda, Arturo Casadevall, Rosana Puccia, Joshua Daniel Nosanchuk, Leonardo Nimrichter et al. · 2012 · Fungal Genetics and Biology
68. A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans
    Mark A. Probert, Xin Zhou, Margaret D Goodall, Simon Andrew Johnston, Ewa Bielska, Elizabeth Ripley Ballou, Robin C. May · 2019 · Infection and Immunity
69. Passive immunization as prophylaxis: when and where will this work?
    Paul M. Dunman · 2003 · Current Opinion in Pharmacology
70. Hybridoma Passage In Vitro May Result in Reduced Ability of Antimannan Antibody To Protect against Disseminated Candidiasis
    Hong Xin, Jim E. Cutler · 2006 · Infection and Immunity
71. Characterization of additional components of the environmental pH-sensing complex in the pathogenic fungus Cryptococcus neoformans
    Kaila M. Pianalto, Kyla S. Ost, Hannah E. Brown, J. Andrew Alspaugh · 2018 · Journal of Biological Chemistry
72. Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule
    Marcellene A. Gates‐Hollingsworth, Thomas R. Kozel · 2009 · Molecular Microbiology
73. Novel Antifungal Compounds Discovered in Medicines for Malaria Venture’s Malaria Box
    Eric H. Jung, David J. Meyers, Jürgen Bosch, Arturo Casadevall · 2018 · mSphere
74. A Phenylthiazole Derivative Demonstrates Efficacy On Treatment of the Cryptococcosis & Candidiasis in Animal Models
    Nívea Pereira de Sá, Caroline Miranda de Lima, Julliana Ribeiro Alves dos Santos, Marliete Carvalho da Costa, Patrícia Pimentel de Barros, Juliana Campos Junqueira, Jéssica Aparecida Vaz, Renata Barbosa de Oliveira, Beth Burgwyn Fuchs, Eleftherios E Mylonakis et al. · 2018 · Future Science OA
75. Antibodies Produced in Response toCryptococcus neoformansPulmonary Infection in Mice Have Characteristics of Nonprotective Antibodies
    Óscar Zaragoza, Arturo Casadevall · 2004 · Infection and Immunity
76. Analysis of Cell Cycle and Replication of Mouse Macrophages after In Vivo and In Vitro Cryptococcus neoformans Infection Using Laser Scanning Cytometry
    Carolina Coelho, Lydia Tesfa, Jinghang Zhang, Johanna Rivera, Teresa Gonçalves, Arturo Casadevall · 2012 · Infection and Immunity
77. Modification of Hinge/Transmembrane and Signal Transduction Domains Improves the Expression and Signaling Threshold of GXMR-CAR Specific to Cryptococcus spp.
    Matheus Henrique dos Santos, Michele Procópio Machado, Pappanaicken R. Kumaresan, Thiago Aparecido da Silva · 2022 · Cells
78. Virulence Factors as Targets for Anticryptococcal Therapy
    Renata Van Der Maas Azevedo, Juliana Rizzo, Márcio Lourenço Rodrigues · 2016 · Journal of Fungi
79. Replicative Aging Remodels the Cell Wall and Is Associated with Increased Intracellular Trafficking in Human Pathogenic Yeasts
    Vanessa K. A. Silva, Somanon Bhattacharya, Natália Kronbauer Oliveira, Anne G. Savitt, Daniel Zamith‐Miranda, Joshua Daniel Nosanchuk, Bettina C. Fries · 2022 · mBio
80. Transplacental transmission of Cryptococcus neoformans to an HIV-exposed premature neonate
    Mahesh C. Patel, Karen Beckerman, Sandra E. Reznik, Rebecca Pellett Madan, David L. Goldman · 2012 · Journal of Perinatology
81. A Predicted Mannoprotein Participates in Cryptococcus gattii Capsular Structure
    Júlia Catarina Vieira Reuwsaat, Heryk Motta, Ane Wichine Acosta Garcia, Carolina Bettker Vasconcelos, Bárbara Machado Marques, Natália Kronbauer Oliveira, Jéssica Rodrigues, Patrícia Aline Gröhs Ferrareze, Susana Frasés, William Lopes et al. · 2018 · mSphere
82. Modulatory immune responses in fungal infection associated with organ transplant - advancements, management, and challenges
    Amir Elalouf, Hadas Elalouf, Ariel Rosenfeld · 2023 · Frontiers in Immunology
83. A potential of propolis on major virulence factors of Cryptococcus neoformans
    Patcharin Thammasit, Anupon Iadnut, Ketsaya Mamoon, Supakit Khacha-ananda, Koollawat Chupradit, Chatchai Tayapiwatana, Watchara Kasinrerk, Yingmanee Tragoolpua, Khajornsak Tragoolpua · 2018 · Microbial Pathogenesis
84. The Cryptococcus neoformans capsule: lessons from the use of optical tweezers and other biophysical tools
    Bruno Pontes, Susana Frasés · 2015 · Frontiers in Microbiology
85. Improved Survival of Mice Deficient in Secretory Immunoglobulin M following Systemic Infection withCryptococcus neoformans
    Krishanthi S. Subramaniam, Kausik Datta, Matthew S. Marks, Liise‐anne Pirofski · 2009 · Infection and Immunity
86. Antifungal Peptide SP1 Damages Polysaccharide Capsule of Cryptococcus neoformans and Enhances Phagocytosis of Macrophages
    Yan Liu, Yang Zhang, Xi Zhao, Weilai Lu, Yuxin Zhong, Yu Vincent Fu · 2023 · Microbiology Spectrum
87. Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapy
    Delio José Mora, Kennio Ferreira Paim, Leonardo Eurípedes Andrade-Silva, Thatiane Bragine, Ivonete Helena Rocha, Bárbara de Melo Ribeiro, Guilherme Henrique Machado, Virmondes Rodrigues, David Nascimento Silva-Teixeira, Wieland Meyer et al. · 2017 · PLoS ONE
88. Cryptococcusantigens and immune responses: implications for a vaccine
    Ashok Kumar Chaturvedi, Floyd L. Wormley · 2013 · Expert Review of Vaccines
89. Restricted Substrate Specificity for the Geranylgeranyltransferase-I Enzyme in Cryptococcus neoformans: Implications for Virulence
    Kyla S. Ost, Elizabeth Ripley Ballou, Connie B. Nichols, J. Andrew Alspaugh · 2013 · Eukaryotic Cell
90. Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen
    Conor J. Crawford, Lorenzo Guazzelli, Scott A. McConnell, Orla McCabe, Clotilde d’Errico, Seth D. Greengo, Maggie P. Wear, Anne Jedlicka, Arturo Casadevall, Stefan Oscarson · 2023 · ACS Infectious Diseases
91. In good company: association between fungal glycans generates molecular complexes with unique functions
    Márcio Lourenço Rodrigues, Leonardo Nimrichter · 2012 · Frontiers in Microbiology
92. Radioimmunotherapy of Cryptococcus Neoformans Spares Bystander Mammalian Cells
    Ruth A. Bryan, Zewei Jiang, Alfred Morgenstern, Frank Bruchertseifer, Arturo Casadevall, Ekaterina Dadachova · 2013 · Future Microbiology
93. Fungi that Infect Humans
    Julia R. Köhler, Bernhard Hube, Rosana Puccia, Arturo Casadevall, John R. Perfect · 2017 · ASM Press eBooks
94. Strain-related differences in antibody-mediated changes in gene expression are associated with differences in capsule and location of binding
    Erin E. McClelland, Arturo Casadevall · 2012 · Fungal Genetics and Biology
95. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan
    Robert W. Maitta · 2004 · Vaccine
96. Normalization of anti-cryptococcal activity and interleukin-12 production after highly active antiretroviral therapy
    Claudia Monari, Arturo Casadevall, Franco Baldelli, Daniela Francisci, Donatella Pietrella, Francesco Bistoni, Anna Vecchiarelli · 2000 · AIDS
97. Structural and functional characterization of glycosylation in an immunoglobulin G1 to Cryptococcus neoformans glucuronoxylomannan
    Fang Wang, Antonio S. Nakouzi, Mauricio Alvarez, Óscar Zaragoza, Ruth Hogue Angeletti, Arturo Casadevall · 2005 · Molecular Immunology
98. Visualization and Documentation of Capsule and Melanin Production in Cryptococcus neoformans
    Connie B. Nichols · 2021 · Current Protocols
99. Equatorial ring-like channels in theCryptococcus neoformanspolysaccharide capsule
    Óscar Zaragoza, Erin E. McClelland, Andrew Telzak, Arturo Casadevall · 2006 · FEMS Yeast Research
100. Thiazole derivatives act on virulence factors of Cryptococcus spp.
     de Sá, Nívea Pereira, de Barros, Patrícia Pimentel, Junqueira, Juliana Campos, Vaz, Jéssica Aparecida, de Oliveira, Renata Barbosa, Rosa, Carlos Augusto, Santos, Daniel Assis, Johann, Susana · 2019 · Medical Mycology